搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
vnda
/
财务摘要
Vanda Pharmaceuticals Inc
VNDA
添加自选
5.130
USD
+0.020
+0.39%
收盘 09-18 16:00(美东)
309.23M
总市值
亏损
市盈率 TTM
Vanda Pharmaceuticals Inc
5.130
+0.020
+0.39%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
VNDA 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Vanda Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
309.23M
股息TTM
0.00
市盈率 TTM
-1.26
每股收益TTM
-4.05
营业收入
216.10M
净利润
-18.90M
净资产收益率
-60.48%
总资产收益率
-44.97%
Vanda Pharmaceuticals Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-1.04
/-0.59
营业收入 / 预测值
50.53M
/61.92M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-125.07%
-1.04
-62.09%
-0.82
-2735.85%
-2.39
-318.28%
-0.38
-494.30%
-0.46
-602.05%
-0.50
-102.50%
-0.08
-3939.50%
-0.09
-393.27%
-0.08
-225.84%
-0.07
-134.35%
-0.04
--
0.00
--
0.03
--
0.06
--
0.12
--
-0.01
--
--
--
--
--
--
--
--
营业收入
-3.92%
50.53M
3.35%
51.72M
7.58%
57.22M
18.06%
56.26M
4.19%
52.59M
5.43%
50.04M
17.48%
53.19M
22.76%
47.65M
9.59%
50.47M
-24.06%
47.46M
-29.79%
45.27M
-40.58%
38.81M
-28.47%
46.06M
3.83%
62.50M
-5.20%
64.48M
-6.82%
65.32M
-5.17%
64.39M
-3.95%
60.19M
0.54%
68.02M
16.23%
70.09M
净利润
-129.77%
-62.51M
-64.67%
-48.57M
-2774.33%
-141.19M
-324.23%
-22.59M
-502.19%
-27.21M
-611.38%
-29.49M
-104.67%
-4.91M
-3986.13%
-5.32M
-397.24%
-4.52M
-227.49%
-4.15M
-134.98%
-2.40M
-95.81%
137.00K
-40.95%
1.52M
150.58%
3.25M
-3.07%
6.86M
-57.92%
3.27M
-73.33%
2.57M
-174.34%
-6.43M
-13.58%
7.08M
30.67%
7.77M
利润率
-139.14%
-123.72%
-59.33%
-93.91%
-2571.82%
-246.76%
-259.33%
-40.15%
-477.96%
-51.73%
-574.72%
-58.94%
-74.21%
-9.24%
-3265.49%
-11.17%
-371.22%
-8.95%
-267.88%
-8.74%
-149.82%
-5.30%
--
0.35%
--
3.30%
--
5.20%
--
10.64%
--
-0.31%
--
--
--
--
--
--
--
--
毛利率
-2.67%
89.02%
0.66%
90.05%
-1.74%
90.24%
0.73%
91.63%
0.39%
91.47%
1.09%
89.46%
1.76%
91.84%
-0.17%
90.97%
-0.51%
91.11%
-3.55%
88.50%
0.57%
90.25%
--
91.13%
--
91.58%
--
91.75%
--
89.74%
--
89.90%
--
--
--
--
--
--
--
--
资产负债率
104.34%
1.74%
122.69%
1.72%
102.37%
1.53%
--
0.86%
--
0.85%
--
0.77%
--
0.76%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
利润表
营业收入
-3.92%
50.53M
3.35%
51.72M
7.58%
57.22M
18.06%
56.26M
4.19%
52.59M
5.43%
50.04M
17.48%
53.19M
22.76%
47.65M
9.59%
50.47M
-24.06%
47.46M
-29.79%
45.27M
-40.58%
38.81M
-28.47%
46.06M
3.83%
62.50M
-5.20%
64.48M
-6.82%
65.32M
-5.17%
64.39M
-3.95%
60.19M
0.54%
68.02M
16.23%
70.09M
营业利润
-65.72%
-63.81M
-22.41%
-50.22M
-292.58%
-40.35M
-184.40%
-31.28M
-279.49%
-38.50M
-344.27%
-41.03M
-44.90%
-10.28M
-83.49%
-11.00M
-253.89%
-10.15M
-560.83%
-9.23M
-207.01%
-7.09M
-253.40%
-6.00M
-182.84%
-2.87M
126.13%
2.00M
-76.69%
6.63M
-63.88%
3.91M
-72.02%
3.46M
-174.16%
-7.67M
134.02%
28.44M
23.76%
10.82M
净利润
-129.77%
-62.51M
-64.67%
-48.57M
-2774.33%
-141.19M
-324.23%
-22.59M
-502.19%
-27.21M
-611.38%
-29.49M
-104.67%
-4.91M
-3986.13%
-5.32M
-397.24%
-4.52M
-227.49%
-4.15M
-134.98%
-2.40M
-95.81%
137.00K
-40.95%
1.52M
150.58%
3.25M
-3.07%
6.86M
-57.92%
3.27M
-73.33%
2.57M
-174.34%
-6.43M
-13.58%
7.08M
30.67%
7.77M
资产负债表
流动资产
-33.03%
264.48M
-28.13%
293.17M
-20.88%
347.26M
-15.01%
367.50M
-10.08%
394.92M
-7.17%
407.91M
1.37%
438.89M
-19.42%
432.39M
-17.68%
439.18M
-17.67%
439.43M
-16.63%
432.95M
5.81%
536.57M
7.37%
533.50M
8.42%
533.71M
8.57%
519.29M
9.81%
507.11M
11.25%
496.89M
16.87%
492.27M
16.90%
478.30M
18.55%
461.81M
流动负债总额
35.01%
164.03M
30.46%
135.58M
45.19%
145.16M
32.30%
117.87M
29.53%
121.49M
11.34%
103.92M
14.01%
99.98M
5.01%
89.09M
7.32%
93.79M
-0.48%
93.34M
-4.09%
87.70M
-8.41%
84.84M
-1.13%
87.40M
3.36%
93.79M
22.87%
91.44M
28.65%
92.62M
22.80%
88.40M
46.87%
90.74M
12.87%
74.42M
17.34%
72.00M
总资产
-33.98%
412.47M
-31.40%
433.52M
-25.49%
488.95M
-6.82%
601.14M
-4.09%
624.75M
-3.18%
631.94M
1.20%
656.20M
0.55%
645.12M
1.51%
651.37M
1.26%
652.68M
2.24%
648.44M
3.19%
641.61M
5.35%
641.68M
6.79%
644.53M
6.81%
634.25M
7.25%
621.79M
7.30%
609.10M
11.11%
603.56M
11.31%
593.79M
12.38%
579.77M
总负债
38.92%
192.28M
26.75%
152.76M
37.48%
161.76M
30.08%
135.14M
27.16%
138.42M
10.89%
120.52M
13.65%
117.66M
5.47%
103.89M
6.95%
108.86M
-0.10%
108.69M
-3.29%
103.53M
-7.19%
98.50M
1.22%
101.78M
7.25%
108.79M
20.46%
107.05M
22.77%
106.13M
16.35%
100.55M
34.24%
101.44M
10.82%
88.86M
14.75%
86.45M
总权益
-54.73%
220.19M
-45.10%
280.76M
-39.25%
327.19M
-13.90%
466.00M
-10.36%
486.33M
-5.99%
511.42M
-1.17%
538.55M
-0.35%
541.22M
0.48%
542.52M
1.54%
544.00M
3.36%
544.91M
5.32%
543.10M
6.16%
539.90M
6.69%
535.74M
4.41%
527.20M
4.53%
515.66M
5.68%
508.55M
7.38%
502.12M
11.40%
504.93M
11.97%
493.32M
现金流量表
经营净额
-103.71%
-31.07M
-51.50%
-50.22M
-1518.99%
-29.42M
-116.90%
-31.63M
-120.15%
-15.25M
-537.93%
-33.15M
51.31%
-1.82M
-611.27%
-14.58M
47.59%
-6.93M
-76.20%
7.57M
-139.63%
-3.73M
-115.97%
-2.05M
-332.54%
-13.22M
686.04%
31.80M
-64.61%
9.42M
36.61%
12.84M
-70.11%
5.69M
-55.99%
4.05M
37.85%
26.61M
0.25%
9.40M
投资净额
321.41%
33.81M
-53.91%
20.23M
1023.62%
44.87M
77.18%
21.36M
-0.05%
-15.27M
340.98%
43.90M
109.12%
3.99M
-65.87%
12.06M
92.00%
-15.26M
-109.73%
-18.22M
-158.05%
-43.78M
262.22%
35.33M
-1208.21%
-190.89M
1623.67%
187.29M
390.13%
75.43M
-31.28%
-21.78M
57.31%
-14.59M
15204.23%
10.87M
-55.81%
-26.00M
65.33%
-16.59M
融资净额
-101.41%
-856.00K
41.39%
-776.00K
-312.90%
-640.00K
--
-517.00K
--
-425.00K
--
-1.32M
--
-155.00K
--
--
--
--
--
--
-100.00%
0.00
-100.00%
0.00
--
--
--
--
-41.88%
605.00K
-98.92%
4.00K
-56.75%
125.00K
-100.00%
0.00
-27.30%
1.04M
201.63%
371.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Vanda Pharmaceuticals Inc的总收入是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,总收入达到了216.10M(同比变化198.77M)。
Vanda Pharmaceuticals Inc的流动资产是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,流动资产为347.26M(同比变化-20.88)。
Vanda Pharmaceuticals Inc的总资产是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的总资产为488.95M(同比变化-25.49)。
Vanda Pharmaceuticals Inc的总负债是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的总负债为161.76M(同比变化37.48)。
Vanda Pharmaceuticals Inc的总权益是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的总权益为327.19M(同比变化-39.25)。
Vanda Pharmaceuticals Inc的净营业收入是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的净营业收入为-151.17M(同比变化-271.79)。
Vanda Pharmaceuticals Inc的净投资是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的净投资为94.86M(同比变化644.23)。
Vanda Pharmaceuticals Inc的净融资是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,Vanda Pharmaceuticals Inc的净融资为-2.91M(同比变化-1774.84)。
Vanda Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-3.74(同比变化-1051.06)。
Vanda Pharmaceuticals Inc的净利润是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,净利润为-220.47M(同比变化-1066.53)。
Vanda Pharmaceuticals Inc的净利润率是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,净利润率为-102.02(同比变化-972.97)。
Vanda Pharmaceuticals Inc的毛利率是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,毛利率为90.72(同比变化0.08)。
Vanda Pharmaceuticals Inc的债务与资产比率是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,债务与资产比率为1.53(同比变化102.37)。
Vanda Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-50.93(同比变化-1359.90)。
Vanda Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-38.51(同比变化-1229.00)。
Vanda Pharmaceuticals Inc的营业利润是多少?
根据Vanda Pharmaceuticals Inc的FY2025财报,营业利润为-151.17M(同比变化-271.79)。